137 related articles for article (PubMed ID: 21930159)
41. Cognitive impairment associated with chemotherapy for cancer: report of a workshop.
Tannock IF; Ahles TA; Ganz PA; Van Dam FS
J Clin Oncol; 2004 Jun; 22(11):2233-9. PubMed ID: 15169812
[TBL] [Abstract][Full Text] [Related]
42. Exposure to oral methylphenidate from adolescence through young adulthood produces transient effects on hippocampal-sensitive memory in rats.
Bethancourt JA; Camarena ZZ; Britton GB
Behav Brain Res; 2009 Aug; 202(1):50-7. PubMed ID: 19447280
[TBL] [Abstract][Full Text] [Related]
43. [Results of a study on fatigue in breast cancer patients receiving adjuvant chemotherapy: the first four days after treatment are the worst].
de Jong N; Kester AD; Schouten HC; Abu-Saad HH; Courtens AM
Pflege Z; 2007 Nov; 60(11):620-5. PubMed ID: 18062627
[TBL] [Abstract][Full Text] [Related]
44. The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice.
Winocur G; Vardy J; Binns MA; Kerr L; Tannock I
Pharmacol Biochem Behav; 2006 Sep; 85(1):66-75. PubMed ID: 16935324
[TBL] [Abstract][Full Text] [Related]
45. Chemotherapy-Induced Cognitive Impairment Is Associated with Cytokine Dysregulation and Disruptions in Neuroplasticity.
Shi DD; Huang YH; Lai CSW; Dong CM; Ho LC; Wu EX; Li Q; Wang XM; Chung SK; Sham PC; Zhang ZJ
Mol Neurobiol; 2019 Mar; 56(3):2234-2243. PubMed ID: 30008071
[TBL] [Abstract][Full Text] [Related]
46. Effects of the cognition impairer MK-801 on learning and memory in mice and rats.
van der Staay FJ; Rutten K; Erb C; Blokland A
Behav Brain Res; 2011 Jun; 220(1):215-29. PubMed ID: 21310186
[TBL] [Abstract][Full Text] [Related]
47. Cognition in female transmembrane domain neuregulin 1 mutant mice.
Chesworth R; Downey L; Logge W; Killcross S; Karl T
Behav Brain Res; 2012 Jan; 226(1):218-23. PubMed ID: 21944941
[TBL] [Abstract][Full Text] [Related]
48. Synergistic effects of selegiline and donepezil on cognitive impairment induced by amyloid beta (25-35).
Tsunekawa H; Noda Y; Mouri A; Yoneda F; Nabeshima T
Behav Brain Res; 2008 Jul; 190(2):224-32. PubMed ID: 18420288
[TBL] [Abstract][Full Text] [Related]
49. [Comparison of adjuvant chemotherapy in breast carcinoma with a combination of cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and AC (doxorubicin, cyclophosphamide). Initial results of a national cooperative study].
Pribylová O; Petruzelka L; Honová H; Fischer J; Bustová I; Siffnerová H; Kůta M; Miller V; Hacklová M; Machácek J; Kohoutek M; Vodvárka P; Kyselá T; Tajblová J; Suk J; Dorazilová V; Bauer J
Sb Lek; 1998; 99(1):25-31. PubMed ID: 9748796
[TBL] [Abstract][Full Text] [Related]
50. Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial.
Cascinu S; Galizia E; Labianca R; Ferraù F; Pucci F; Silva RR; Luppi G; Beretta GD; Berardi R; Scartozzi M
Cancer Chemother Pharmacol; 2011 Jul; 68(1):37-43. PubMed ID: 20821330
[TBL] [Abstract][Full Text] [Related]
51. Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial.
Leonard RC; Lind M; Twelves C; Coleman R; van Belle S; Wilson C; Ledermann J; Kennedy I; Barrett-Lee P; Perren T; Verrill M; Cameron D; Foster E; Yellowlees A; Crown J;
J Natl Cancer Inst; 2004 Jul; 96(14):1076-83. PubMed ID: 15265969
[TBL] [Abstract][Full Text] [Related]
52. Clinical predictors of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adjuvant doxorubicin and cyclophosphamide.
Shih V; Wan HS; Chan A
Ann Pharmacother; 2009 Mar; 43(3):444-52. PubMed ID: 19193584
[TBL] [Abstract][Full Text] [Related]
53. Effects of chemotherapeutic agents on male germ cells and possible ameliorating impact of antioxidants.
Ghafouri-Fard S; Shoorei H; Abak A; Seify M; Mohaqiq M; Keshmir F; Taheri M; Ayatollahi SA
Biomed Pharmacother; 2021 Oct; 142():112040. PubMed ID: 34416630
[TBL] [Abstract][Full Text] [Related]
54. Systemic cisplatin exposure during infancy and adolescence causes impaired cognitive function in adulthood.
John T; Lomeli N; Bota DA
Behav Brain Res; 2017 Feb; 319():200-206. PubMed ID: 27851909
[TBL] [Abstract][Full Text] [Related]
55. Doxorubicin and cisplatin induced cognitive impairment: The possible mechanisms and interventions.
Ongnok B; Chattipakorn N; Chattipakorn SC
Exp Neurol; 2020 Feb; 324():113118. PubMed ID: 31756316
[TBL] [Abstract][Full Text] [Related]
56. The Main Metabolites of Fluorouracil + Adriamycin + Cyclophosphamide (FAC) Are Not Major Contributors to FAC Toxicity in H9c2 Cardiac Differentiated Cells.
Reis-Mendes A; Carvalho F; Remião F; Sousa E; Bastos ML; Costa VM
Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30862114
[TBL] [Abstract][Full Text] [Related]
57. Cognitive impairments caused by oxaliplatin and 5-fluorouracil chemotherapy are ameliorated by physical activity.
Fardell JE; Vardy J; Shah JD; Johnston IN
Psychopharmacology (Berl); 2012 Mar; 220(1):183-93. PubMed ID: 21894483
[TBL] [Abstract][Full Text] [Related]
58. Bifidobacteria modulate cognitive processes in an anxious mouse strain.
Savignac HM; Tramullas M; Kiely B; Dinan TG; Cryan JF
Behav Brain Res; 2015; 287():59-72. PubMed ID: 25794930
[TBL] [Abstract][Full Text] [Related]
59. Neurobiological Mechanisms of Chemotherapy-induced Cognitive Impairment in a Transgenic Model of Breast Cancer.
Winocur G; Berman H; Nguyen M; Binns MA; Henkelman M; van Eede M; Piquette-Miller M; Sekeres MJ; Wojtowicz JM; Yu J; Zhang H; Tannock IF
Neuroscience; 2018 Jan; 369():51-65. PubMed ID: 29113931
[TBL] [Abstract][Full Text] [Related]
60. Dermatologic changes after systemic cancer therapy.
Nixon DW; Pirozzi D; York RM; Black M; Lawson DH
Cutis; 1981 Feb; 27(2):181-2, 186-8, 192-4. PubMed ID: 6164518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
